APP and Alzheimer disease: Studies have shown that the E693Delta APP mutation produces an Aβ variant more resistant to proteolytic degradation and showing enhanced oligomerization but no fibrillization, which is more likely to induce early symptoms of AD, indicating that the level of Aβ aggregates is closely related to the progression of AD [27].